Search Results
Jul 10, 2026, 17:00 ET Fine, Kaplan and Black, R.P.C.宣布，若您曾于2009年5月1日至2019年12月31日期间在美国境内支付或报销过特定处方仿制药费用，现可提交集体诉讼和解索赔表
www.GenericDrugsEndPayerSettlement.com您可能已经看到过关于集体诉讼案件In re Generic Pharmaceuticals Antitrust Litigation（关于仿制药反垄断诉讼案）（案号：16-MD-2724，宾夕法尼亚州东区联邦地区法院）中，与Sandoz Inc.和Fougera Pharmaceuticals Inc.（合称“Sandoz”）、Apotex Corp.（“Apotex”）、Heritage Pharmaceuticals Inc.、Emcure Pharmaceuticals,
More news about: Fine, Kaplan and Black, R.P.C.
Jul 10, 2026, 17:00 ET Fine, Kaplan and Black, R.P.C. 宣佈，若您於 2009 年 5 月 1 日至 2019 年 12 月 31 日期間曾在美國支付或償付若干處方仿製藥費用，現可提交集體訴訟和解申索表格
www.GenericDrugsEndPayerSettlement.com您可能曾看過有關集體訴訟 In re Generic Pharmaceuticals Antitrust Litigation，案件編號：16-MD-2724（美國賓夕法尼亞州東區聯邦地區法院）的先前通知，當中涉及與 Sandoz Inc. 及 Fougera Pharmaceuticals Inc.（統稱「Sandoz」）、Apotex Corp.（「Apotex」）、Heritage Pharmaceuticals Inc.、Emcure Pharmaceuticals,
More news about: Fine, Kaplan and Black, R.P.C.
Jul 10, 2026, 17:00 ET Fine, Kaplan and Black, R.P.C. Announces Claim Forms Now Being Accepted for Class Action Settlements If You Paid or Reimbursed for Certain Prescription Generic Drugs in the United States Between May 1, 2009 and December 31, 2019
Pharmaceuticals U.S.A., Inc. ("Taro") ("Sun/Taro" for both entities) in the class action lawsuit In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724 (E.D. Pa.).The Court has granted final approval of these settlements, and Settlement Class Members may now file a claim to receive settlement
More news about: Fine, Kaplan and Black, R.P.C.
Jul 10, 2026, 17:00 ET Fine, Kaplan and Black, R.P.C. anuncia que ya se aceptan formularios de reclamación para los acuerdos de demanda colectiva si pagó o recibió un reembolso por determinados medicamentos genéricos recetados en Estados Unidos entre el 1 de mayo de 2009 y el 31 de diciembre de 2019
("Sun/Taro" para ambas entidades) en la demanda colectiva en referencia al litigio antimonopolio de productos farmacéuticos genéricos, N.º 16-MD-2724 (Distrito Este de Pensilvania).El Tribunal ha otorgado la aprobación definitiva a estos acuerdos, y los miembros del grupo del acuerdo
More news about: Fine, Kaplan and Black, R.P.C.
Jul 10, 2026, 15:54 ET Gundry MD Celebrates National Day on July 11 with Exclusive Offers and Antioxidant-Rich Health Tips
Gundry MD Polyphenol Rich Olive Oil for the first time, or restock for the celebration, can use code PODCAST25 at checkout for 25% off regular-priced items during the National Polyphenol Day promotional period.About Gundry MDFounded in 2015, Gundry MD is dedicated to
More news about: Gundry MD
Jul 10, 2026, 13:28 ET The Inner Circle acknowledges George D. McSherry, MD as a Pinnacle Professional of The Year
/PRNewswire/ -- Prominently featured in The Inner Circle, George D. McSherry, MD is acknowledged as a Pinnacle Professional of The Year for his contributions as Pediatric Infectious Disease Specialist. George D. McSherry, MD, is a distinguished pediatric infectious disease specialist whose career has
More news about: The Inner Circle
Jul 10, 2026, 10:44 ET MY DR NOW Opens Fort Worth Clinic as Demand Grows for Accessible, Same-Day Healthcare in Texas
the same clinic — during the workweek, on the weekend, by appointment or walk-in.About MY DR NOWFounded in 2007 by Payam Zamani, MD, and headquartered in Phoenix, MY DR NOW has reimagined primary care around accessibility, convenience and continuity. Through a consumer-focused healthcare
More news about: MY DR NOW
Jul 10, 2026, 09:01 ET OpenEvidence Launches EvidenceGrade™, Empowering Physicians To See the Strength of Cited Evidence Beneath Each AI Answer
certain, and when a clinician acts on an answer, it's imperative they understand how much weight the underlying evidence can bear," said Samuel Finlayson, MD, PhD, Senior Vice President of Medical AI at OpenEvidence. "Expert research appraisal teams do invaluable work, but they can't cover every question that
More news about: OpenEvidence
Jul 10, 2026, 09:00 ET Nanoscope Therapeutics to Present at 2026 American Society of Retina Specialists Annual Scientific Meeting
Jordi Monés, MD, PhD, to Introduce First Direct-to-Phase 2 Randomized, Controlled Trial of Optogenetic Therapy in Macular DegenerationBenjamin Bakall, MD, PhD, to Present Durable 3-Year REMAIN Follow-Up Data from the RESTORE Phase 2b/3 Trial of MCO-010 in Retinitis
More news about: Nanoscope Therapeutics
Jul 10, 2026, 08:57 ET NABJ Releases RFP for Executive Search Firm to Support Executive Director Recruitment
July 21 as the organization continues its process to identify its next Executive Director. COLLEGE PARK, Md., July 10, 2026 /PRNewswire/ -- The
More news about: National Association of Black Journalists
Jul 10, 2026, 08:00 ET Sharon X Li, M.D., Now Offering Patients the Hybrid Choice™ Concierge Program from Concierge Choice Physicians
For more information on the program or to join, contact Concierge Choice Physicians at (877) 888-5590.About Sharon X. Li, MDSharon X. Li, MD is a board-certified internal medicine physician at Medical Clinic of Houston, L.L.P. who is dedicated to helping adults
More news about: Concierge Choice Physicians
Jul 10, 2026, 07:10 ET Rule 10b-5 Securities Class Action Exposure Second Highest in 8 Years
BETHESDA, Md., July 10, 2026 /PRNewswire/ -- Today, Securities Analytics Research (SAR) published the
More news about: SAR
Jul 10, 2026, 03:00 ET EDCare's Evidence-Based Approach to Comprehensive Eating Disorder Recovery Featured on "All Access Hosted by Andy Garcia"
with eating disorders."Eating disorders require coordinated, specialized treatment delivered by a multidisciplinary team," said Danielle Burton, MD, Medical Director of EDCare. "In athletic environments, the drive to perform and push through discomfort can sometimes delay recognition of early concerns.
More news about: All Access
Jul 10, 2026, 02:00 ET Kanadevia Group Accelerating Global Expansion of Green Hydrogen-related Businesses
https://drive.google.com/file/d/1RAbrPkw5m3zTGS1md6RYz_l5lyf-Be9D/view?usp=sharingImage: hydrogen production system
More news about: Kanadevia Corporation
Jul 09, 2026, 16:05 ET CAE to transfer U.S. stock exchange listing to Nasdaq
statements made in this press release and the risks and uncertainties affecting CAE's business can be found in CAE's Management's Discussion and Analysis (MD&A) for the fiscal year ended March 31, 2026, available on CAE's website (
More news about: CAE Inc.
Jul 09, 2026, 16:00 ET Aritzia Reports First Quarter Fiscal 2027 Financial Results
found in the Q1 2027 MD&A and is incorporated by reference. This information is found in the sections entitled "How We Assess the Performance of our Business", "Non-IFRS Financial Measures and Retail Industry Metrics" and "Selected Financial Information" of the Q1 2027 MD&A which is available under
More news about: Aritzia Inc.
Jul 09, 2026, 15:45 ET Allegheny Health Network Names Allan Klapper, MD, President of AHN Grove City Hospital
CITY, Pa., July 9, 2026 /PRNewswire/ -- Allegheny Health Network (AHN) today announced that Allan Klapper, MD, has been named the president of
More news about: Allegheny Health Network
Jul 09, 2026, 13:06 ET GEMMABio Awarded ARPA-H Funding to Pursue Innovative Base-editing Strategy for Rare Liver Diseases
medicines for devastating rare diseases and to distribute these treatments globally," said GEMMABio President and Chief Executive Officer James M. Wilson, MD, PhD. "We believe our work with Profluent will lead to a novel and powerful base-editing approach that can be applied across diverse mutations and genetic
More news about: GEMMA Biotherapeutics
Jul 09, 2026, 12:00 ET The Biggest Revenue Opportunity in Your Practice Isn't More Patients; It's the Revenue You're Already Earning, says ModuleMD Report
ogo: https://mma.prnewswire.com/media/2314317/6023145/Module_MD_Logo.jpg
More news about: ModuleMD LLC
Jul 09, 2026, 11:18 ET The Jackson Laboratory, with the Broad Institute and Partners, Selected for ARPA-H THRIVE Award to Advance Gene Editing Platform for Pediatric Epilepsies and Rare CNS Diseases
the scientific, technical, clinical, and translational capabilities needed to advance the next generation of precision medicines," said Winston Yan, MD, PhD, Co-founder & Director of the Center for Therapeutic Genetics and Lead Investigator for PERC at the Broad Institute. "With support from ARPA-H,
More news about: The Jackson Laboratory
Jul 09, 2026, 11:15 ET Children's Hospital of Philadelphia Secures Five-year, up to $38.9 Million ARPA‑H Award to Advance Personalized Gene Editing Therapies
Rebecca Ahrens-Nicklas, MD, PhD, Director of CHOP's
More news about: Children's Hospital of Philadelphia
Jul 09, 2026, 11:05 ET GLP-1 Boom Drives Rise in Post-Weight-Loss Body Contouring at Blackhawk Plastic Surgery
www.blackhawkplasticsurgery.com.About Premier Plastic Surgery PartnersFounded in 2023 by Jeffrey H. Spiegel, MD, FACS, Ross A. Clevens, MD, FACS, and Stephen J. Ronan, MD, FACS, Premier is the nation's first physician-led, majority physician-owned partnership platform for plastic and facial
More news about: Premier Plastic Surgery Partners
Jul 09, 2026, 11:02 ET Hyundai Hope on Wheels and MD Motivator Campaign Win Two PR Daily Awards for Social Media Excellence
collaboration with social media creator Zachery Dereniowski, known to millions as MD Motivator, to elevate awareness of pediatric cancer and inspire acts of compassion through authentic storytelling. The campaign is part of Hyundai's
More news about: Hyundai Hope On Wheels
Jul 09, 2026, 11:00 ET ELEPHAS BIOSCIENCES WELCOMES HOWARD A. 'SKIP' BURRIS III, MD TO THE COMPANY'S BOARD OF DIRECTORS
company that has developed an innovative live tissue platform for immunotherapy response prediction, today announced that Howard A. 'Skip' Burris III, MD has joined the Elephas Board of Directors. A pioneer in expanding early-phase drug development beyond academic medical centers and into community oncology
More news about: Elephas
Jul 09, 2026, 10:30 ET NASA Federal Credit Union Earns Celent Model Risk Manager of the Year Award for AI-Powered Modernization
UPPER MARLBORO, Md., July 9, 2026 /PRNewswire/ -- NASA Federal Credit Union has been named a recipient of Celent's Model Risk Manager of the Year Award, recognizing the credit union's innovative use of artificial intelligence
More news about: NASA Federal Credit Union